Hikma Pharmaceuticals plc (PK) (HKMPY)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.95B | 1.94B | 2.07B | 2.21B | 2.34B | 2.55B | 2.52B | 2.88B |
Operating Income | 323M | -752M | 378M | 482M | 613M | 620M | 287M | 399M |
Pre Tax Income | 210M | -738M | 293M | 491M | 558M | 544M | 233M | 279M |
Net Income | 155M | -843M | 282M | 486M | 431M | 421M | 188M | 192M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.643 | -3.503 | 1.168 | 2.006 | 1.771 | 1.723 | 0.807 | 0.821 |
EBIT | 323M | -754M | 375M | 479M | 611M | 619M | 287M | 399M |
EBITDA | 469M | 489M | 499M | 581M | 704M | 765M | 656M | 658M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.